Wesley P. Wheeler, MBA has been named chief executive officer of Marken. He succeeds Gerard Barba, who will remain the chairman of the board. “As the nature of biopharmaceutical R&D changes, well controlled clinical supply chains will be a significant factor in the success of key life science companies and the industries that support them. The Board and I feel that Wes can bring his experience from the drug manufacturing, biotechnology and traditional pharmaceutical industries to au...